{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:03:34Z","timestamp":1761102214825},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40001-016-0212-2","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T11:45:06Z","timestamp":1462967106000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Serum prolactin as a biomarker for the study of intracerebral dopamine effect in adult patients with phenylketonuria: a cross-sectional monocentric study"],"prefix":"10.1186","volume":"21","author":[{"given":"Eszter","family":"Juh\u00e1sz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Simonova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Pat\u00f3cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Reismann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,11]]},"reference":[{"key":"212_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2004.03.006","volume":"82","author":"N Blau","year":"2004","unstructured":"Blau N, Erlandsen H. The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Mol Genet Metab. 2004;82:101\u201311.","journal-title":"Mol Genet Metab"},{"issue":"Suppl. 2","key":"212_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01799701","volume":"9","author":"F G\u00fcttler","year":"1986","unstructured":"G\u00fcttler F, Lou H. Dietary problems of phenylketonuria: effect on CNS transmitter and their possible role in behaviour and neurophysiological function. J Inherit Metab Dis. 1986;9(Suppl. 2):169\u201377.","journal-title":"J Inherit Metab Dis"},{"key":"212_CR3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/8904_2014_386","volume":"20","author":"M Velema","year":"2015","unstructured":"Velema M, Boot E, Engelen M, Hollak C. Parkinsonism in phenylketonuria: a consequence of dopamine depletion? JIMD Report. 2015;20:35\u20138.","journal-title":"JIMD Report"},{"key":"212_CR4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0006-8993(72)90653-1","volume":"47","author":"CM McKean","year":"1972","unstructured":"McKean CM. The effect of high phenylalanine concentration on serotonin and catecholamine metabolism in the human brain. Brain Res. 1972;47:469\u201376.","journal-title":"Brain Res"},{"key":"212_CR5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4684-3860-4_16","volume":"133","author":"HC Curtius","year":"1981","unstructured":"Curtius HC, Niederwieser A, Viscontini M, Leimbacher W, Wegmann H, Blehova B, Rey F, Schaub J, Schmidt H. Serotonin and dopamine synthesis in phenylketonuria. Adv Exp Med Biol. 1981;133:277\u201391.","journal-title":"Adv Exp Med Biol"},{"key":"212_CR6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1026725122142","volume":"23","author":"J Denecke","year":"2000","unstructured":"Denecke J, Schlegel W, Koch HG, Feldmann R, Harms E, Weglage J. Prolactin, a marker for cerebral dopamine deficiency in patients suffering from phenylketonuria (PKU)? J Inherit Metab Dis. 2000;23:849\u201351.","journal-title":"J Inherit Metab Dis"},{"issue":"12","key":"212_CR7","doi-asserted-by":"crossref","first-page":"e0143833","DOI":"10.1371\/journal.pone.0143833","volume":"10","author":"D Vliet van","year":"2015","unstructured":"van Vliet D, Bruinenberg VM, Mazzola PN, van Faassen MHJR, de Blaauw P, Kema IP, Heiner-Fokkema MR, van Anholt RD, van der Zee EA, van Spronsen FJ. Large neutral amino acid supplementation exerts its effect through three synergistic mechanisms: proof of principle in phenylketonuria mice. PLoS One. 2015;10(12):e0143833.","journal-title":"PLoS One"},{"key":"212_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1750-1172-8-133","volume":"8","author":"MJ Groot de","year":"2013","unstructured":"de Groot MJ, Hoeksma M, Reijngoud DJ, de Valk HW, Paans AM, Suaer PJ, van Spronsen FJ. Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis. Orphanet J Rare Dis. 2013;8:133.","journal-title":"Orphanet J Rare Dis"},{"key":"212_CR9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1005694122277","volume":"23","author":"AB Burlina","year":"2000","unstructured":"Burlina AB, Bonafe L, Ferrari V, Suppiej A, Zacchello F, Burlina AP. Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment. J Inherit Metab Dis. 2000;23:313\u20136.","journal-title":"J Inherit Metab Dis"},{"key":"212_CR10","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/edrv.22.6.0451","volume":"22","author":"N Ben-Jonathan","year":"2001","unstructured":"Ben-Jonathan N, Hnasko R. Dopamine as a Prolactin (PRL) inhibitor. Endocr Rev. 2001;22:724\u201363.","journal-title":"Endocr Rev"},{"key":"212_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01799437","volume":"19","author":"M Spada","year":"1996","unstructured":"Spada M, Ferraris S, Ferrero GB, Sartore M, Lanza C, PErfetto F, de Sanctis L, Dompe C, Blau N, Ponzone A. Monitoring treatment in tetrahydrobiopterin deficiency by serum prolactin. J Inherit Metab Dis. 1996;19:231\u20133.","journal-title":"J Inherit Metab Dis"},{"key":"212_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ymgme.2014.11.009","volume":"114","author":"D Vliet van","year":"2015","unstructured":"van Vliet D, Anjema K, Jahja R, de Groot MJ, Liemburg GB, Heiner-Fokkema MR, van der Zee EA, Derks TGJ, Kema IP, van Spronsen FJ. BH4 treatment in BH4-responsive PKU patients: preliminary data on blood prolactin concentrations suggest increased cerebral dopamin concentrations. Mol Genet Metab. 2015;114:29\u201333.","journal-title":"Mol Genet Metab"},{"key":"212_CR13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1210\/jcem-70-3-814","volume":"70","author":"HE Carlson","year":"1990","unstructured":"Carlson HE, Hyman DB, Blitzer MG. Evidence for an intracerebral action of phenylalanine in stimulation of prolactin secretion: interaction of large neutral amino acids. J Clin Endocrinol Metab. 1990;70:814\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"212_CR14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0026-0495(92)90211-R","volume":"41","author":"HE Carlson","year":"1992","unstructured":"Carlson HE, Hyman DB, Bauman C, Koch R. Prolactin responses to phenylalanine and tyrosin in phenylketonuria. Metabolism. 1992;41:518\u201321.","journal-title":"Metabolism"},{"key":"212_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1172\/JCI111695","volume":"75","author":"W Krause","year":"1985","unstructured":"Krause W, Halminski M, McDonald L, Dembure P, Salvo R, Freides D, Elsas L. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man. J Clin Invest. 1985;75:40\u20138.","journal-title":"J Clin Invest"},{"key":"212_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2265.1998.00358.x","volume":"48","author":"KH Schulpis","year":"1998","unstructured":"Schulpis KH, Papakonstantinou E, Michelakakis H, Theodoridis Th, Papandreou UR, Constantopoulos A. Elevated serum prolactin concentration in phenylketonuric patients on a \u2018loose diet\u2019. Clin Endocrinol. 1998;48:99\u2013101.","journal-title":"Clin Endocrinol"},{"key":"212_CR17","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/ajcn\/64.6.916","volume":"64","author":"FJ Spronsen van","year":"1996","unstructured":"van Spronsen FJ, van Dijk T, Smit GP, van Rijn M, Reijngoud DJ, Berger R, Heymans HS. Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria. Am J Clin Nutr. 1996;64:916\u201321.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"212_CR18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.jcbfm.9600571","volume":"28","author":"C Landvogt","year":"2008","unstructured":"Landvogt C, Mengel E, Bartenstein P, Buchholz HG, Schreckenberger M, Siessmeier T, Scheurich A, Feldmann R, Weglage J, Cumming P, Zepp F, Ullrich K. Reduced cerebral fluoro-l-dopamine uptake in adult patients suffering from phenylketonuria. J Cereb Blood Flow Metab. 2008;28(4):824\u201331.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"212_CR19","first-page":"119","volume":"47","author":"KD Wang","year":"2009","unstructured":"Wang KD, Zhou ZS, Shen M, Hong W, Yu WM. Quantification of phenylalanine in the brain of patients with hyperphenylalaninemia by (1)H magnetic resonance spectroscopy. Zhonghou Er Ke Za Zhi. 2009;47(2):119\u201323.","journal-title":"Zhonghou Er Ke Za Zhi"},{"issue":"6","key":"212_CR20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1023\/A:1021234730512","volume":"25","author":"J Weglage","year":"2002","unstructured":"Weglage J, Wiedermann D, Denecke J, Feldmann R, Koch HG, Ullrich K, M\u00f6ller HE. Individual blood-brain barrier phenylalanine transport in siblings with classical phenylketonuria. J Inherit Metab Dis. 2002;25(6):431\u20136.","journal-title":"J Inherit Metab Dis"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-016-0212-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T14:31:51Z","timestamp":1567866711000},"score":1,"resource":{"primary":{"URL":"http:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-016-0212-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,11]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1186\/s40001-016-0212-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,11]]},"article-number":"22"}}